Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 465,293 | 680,112 | 835,870 | 861,312 | 976,690 |
| Marketable Securities | 1,244,453 | 1,180,484 | 1,425,162 | 1,553,409 | 1,382,746 |
| TOTAL | $1,769,176 | $1,946,332 | $2,358,634 | $2,519,077 | $2,413,616 |
| Non-Current Assets | |||||
| PPE Net | 99,309 | 104,126 | 103,758 | 105,609 | 100,226 |
| Investments And Advances | 39,617 | 52,358 | 49,187 | 23,927 | 34,102 |
| Intangibles | 42,394 | 42,527 | 49,559 | 49,692 | 49,825 |
| Other Non-Current Assets | 94,399 | 98,531 | 104,798 | 103,783 | 98,201 |
| TOTAL | $275,719 | $297,542 | $307,302 | $283,011 | $282,354 |
| Total Assets | $2,044,895 | $2,243,874 | $2,665,936 | $2,802,088 | $2,695,970 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,627 | 12,362 | 12,149 | 6,422 | 2,722 |
| Accrued Expenses | 146,111 | 197,580 | 455,922 | 489,090 | 282,616 |
| TOTAL | $165,050 | $225,623 | $485,288 | $511,029 | $308,203 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,312 | 15,681 | 17,217 | 15,517 | 22,865 |
| Other Non-Current Liabilities | 151,553 | 154,836 | 153,443 | 159,889 | 164,820 |
| TOTAL | $204,760 | $208,043 | $209,847 | $213,096 | $237,912 |
| Total Liabilities | $369,810 | $433,666 | $695,135 | $724,125 | $546,115 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134,521 | 134,251 | 133,977 | 133,531 | 133,116 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -121,851 | 41,562 | 236,337 | 377,237 | 478,840 |
| Other shareholders' equity | -1,900 | -2,903 | -3,175 | -9,122 | -11,880 |
| TOTAL | $1,675,085 | $1,810,208 | $1,970,801 | $2,077,963 | $2,149,855 |
| Total Liabilities And Equity | $2,044,895 | $2,243,874 | $2,665,936 | $2,802,088 | $2,695,970 |